Dalin Group
View allAll Photos Tagged IPO
Prima della fascia Ipo di tarda mattinata, l'EC 47 (espletato da un ETR 610) sfreccia attraverso l'affascinante impianto di Premosello-Chiovenda.
"Illinois Central" ET44AC 3008 takes the lead of CN 424 at the former junction of the Strathroy Sub and Ilderton Spur/Exeter Sub. Last year, the heritage units 3008 and 3023 were used on a special service in Wisconsin, where they both had their "IPO 25" stickers removed. This has left them both with zero external CN markings.
December 11, 2024.
Recently unveiled Canadian National ET44AC heritage unit 3115 glistens in the morning sun at Capreol, Ontario. The commemorative paint scheme represents 25 years of privatization.
CN 8898 has a sticker on its nose commemorating the 25th anniversary of CN's initial public offering as it leads a 600-axle long CN 120 through the snow.
used by IPOS as a shotgun for close quarters combat, heats up solid canisters and launches the shrapnel at anything at the end of the barrel, holds one hundred canisters and does not overheat.
more pictures: www.artstation.com/thormagniss
wips: twitter.com/StudiosTiten
its a quad focusing laser that should be enough, this thing is big bulky and ugly, but it gets the job done.
more pictures: www.artstation.com/thormagniss
wips: twitter.com/StudiosTiten
Yesterday, my employer, Allegro, went public in what was Poland's largest IPO so far and Europe's largest this year. Hopefully, the charts continue growing as in this picture :) Origami tessellation, single sheet of paper, no cutting or glue, just folding.
After a multi-year expansion of company formation and in biopharma valuations, 2018 was a year of heightened market volatility. Investors’ eagerness to support new modalities enabled more than 50 biotech IPOs, but with much less mature clinical development progress than traditionally demonstrated. More than half those companies are trading below their IPO prices, however, complicating conditions for the next new offering. As interest rate worries, international trade disputes, and regulatory reimbursement uncertainty have increased, biopharma stock indexes have seen significant corrections. With historically high valuations experiencing sudden dips, M&A deal-making seems to have reignited with notable, multi-billion dollar deals in recent weeks. This session will assemble market experts to discuss what forces continue to shape performance within the sector and what opportunities the market correction can reveal for investors and companies seeking resources to deliver the next wave of innovative therapies for patients.
Speakers
Sara Michelmore, MacDougall
Katherine Andersen, Silicon Valley Bank (SVB)
Noël Brown, Cantor Fitzgerald
Andrew Gitkin, Piper Jaffray
Geoffrey Goodman, Wells Fargo Securities
Philip Ross, J.P. Morgan
Jennifer Sheng, Citi
Yaron Werber, Cowen
*explore-september 13, 2008. thank you all for the views, comments and faves.*
i know many of you are in autumn but us folks here in manila are still going through a wee bit of the typhoon season.
ipu ipo is the tagalog (most widely used dialect in the philippines) term for cyclone / tornado. BUT... i don't think this is and i guess it must just be a really heavy down pour. this was taken on one of the rainiest weeks i can remember. had a friend over that day so you can check out his version of this post apocalyptic scene. mind you, his version was taken with the nikon d700-one of the most amazing camera's i have ever held with my oily paws. you can also compare the colors and details that the sensor picks up between my teeny weeny canon g7 and the machine gun full frame nikon d700.
this is a 3 exposure hdr with photomatix and further processed with photoshop.